- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
REPORT ON VODOCAT AT THE DEPARTMENT OF CARDIOVASCULAR ENDONESIA – CHO RAY HOSPITAL
On July 4, 2023, Medbolide CPDP Company attended the weekly scientific and technical activity of the Department of Cardiology - Cho Ray Hospital. The event had the participation of more than 50 doctors specializing in cardiology, chaired by Head of Department Associate Professor, Dr. Hoang Van Sy.
During the event, Dang Quang Toan, M.D. 1, represented the Company and reported on VODOCAT (Torsemide 5 mg). Torsemide is a loop diuretic, with a different and superior mechanism of action compared to older diuretics, such as Furosemide. Torsemide is a new solution for diuretic resistance - a problem when using older diuretics.
The report attracted the attention and appreciation of doctors about VODOCAT products. Medbolide Joint Stock Company is proud to be a trusted partner of Cho Ray Hospital in providing quality and effective medical products that contribute to people's health care.
Readers comments